Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0848332 (
Spots
)
453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Epigallocatechin gallate (EGCG) is the major active polyphenol in green tea. Protein interaction with EGCG is a critical step in the effects of EGCG on the regulation of various key proteins involved in signal transduction. We have identified a novel molecular target of EGCG using affinity chromatography, two-dimensional electrophoresis, and mass spectrometry for protein identification.
Spots
of interest were identified as the intermediate filament,
vimentin
. The identification was confirmed by Western blot analysis using an anti-
vimentin
antibody. Experiments using a pull-down assay with [3H]EGCG demonstrate binding of EGCG to
vimentin
with a Kd of 3.3 nm. EGCG inhibited phosphorylation of
vimentin
at serines 50 and 55 and phosphorylation of
vimentin
by cyclin-dependent kinase 2 and cAMP-dependent protein kinase. EGCG specifically inhibits cell proliferation by binding to
vimentin
. Because
vimentin
is important for maintaining cellular functions and is essential in maintaining the structure and mechanical integration of the cellular space, the inhibitory effect of EGCG on
vimentin
may further explain its anti-tumor-promoting effect.
...
PMID:The intermediate filament protein vimentin is a new target for epigallocatechin gallate. 1571 70